Coinfection with HIV-1 and human T-cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS
Article Abstract:
Various AIDS-related virologic, clinical and immunologic parameters are analyzed to study the relation between AIDS and its coinfection with HIV-1 and human T-cell lymphotropic virus (HTLV) types I and II. The results show that the antiretroviral treatment is only successful in controlling HIV-I infection among the patients as HIV-I and HTLV-II elucidates cell counts for a longer period of time.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Virostatics: A new frontier in the treatment of HIV/AIDS
Article Abstract:
The generalized qualitative impairment of lymphocyte function observed during HIV disease progression is discussed and the need for improving highly active antiretroviral therapy (HAART) is emphasized. To slow immune pathology, more consideration should be given to the reconstitution of the immune system by increasing the number of restoring or improving biological function of T-cell subsets.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Evaluation of HIV-1 p24 antigenemia and level of CD8(super +)CD38(super +) T cells as surrogate markers of HIV- 1 RNA viral load in HIV-1-infected patients in Dakar, Senegal
- Abstracts: Desertification called global health threat. Gene discovery speeds progeria research. Syphilis rates rise among men
- Abstracts: Ichthyosis. The legal and clinical implications of crushing tablet medication. How to maintain optimal glycaemic-control in diabetes
- Abstracts: Are nurses ready to take on the BNF? A stepping stone to full prescribing. Implications of non-medical prescribing of controlled drugs
- Abstracts: Circulating levels of the antiangiogenic marker sFLT-1 are increased in the first versus second pregnancies. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy